Production

Bbca Brings New Valine Capacity Online

In February, BBCA Pharmaceutical began production at a new valine plant at Bengbu, Anhui province, with a nameplate capacity of 20,000 tonnes/year.

Daesang Halts Lysine Production

Low prices caused Daesang to stop production of lysine HCl at its factory in Gunsan, South Korea in late January. The company told Feedinfo production would restart in May. It has also said that it has plans to produce specialty amino acids in cooperation with its Chinese partner Heilongjiang Chengfu Food Group in the coming years.

Yufeng Expanding Lysine Production

Meanwhile, Yufeng will be launching additional lysine production in mid-2023. The first phase of Yufeng’s lysine project, located in Zhumadian, Henan province, is expected to have a nameplate capacity of 200,000 tonnes/year.

Cj Bio Updates On Amino Acid Plans In Brazil And China

CJ Bio’s 10,000 tonne per year expansion of tryptophan capacity in Piracicaba, Brazil is expected online in Q3 of this year. The company will also be making its Thr Pro threonine range in Brazil for the first time when a 27,000 tonne production line comes online in H2. Moreover, although valine production resumed at CJ Bio’s Shenyang, Liaoning plant in late January, the company has told Feedinfo that it will be switching over to isoleucine at this site as of May, as there are fewer suppliers for this product.

NHU-SINOPEC MHA JV TO BREAK GROUND

Sources at NHU told Feedinfo in February that construction would soon begin on a methionine hydroxy analogue (MHA) plant in Ningbo, Zhejiang. The project is a joint venture with Sinopec ZRCC and is expected to come online by the end of 2024.

EVONIK EXPANDING METHIONINE PRODUCTION IN SINGAPORE; BACKWARDS INTEGRATION IN EUROPE

Evonik announced an expansion to its DL-methionine capacity in Singapore, where nameplate capacity will increase 13% to 340,000 tonnes per year by Q3 2024, according to current projections. Moreover, this quarter Evonik also brought online a new EUR 25 million methylmercapto propionaldehyde (MMP) production unit at its site in Wesseling, Germany; this product is integrated with Evonik’s methionine production hub in Antwerp, Belgium.

Feedinfo can help you get your company’s message out in front of a global audience of animal nutrition professionals. Learn more about our Industry Perspectives offerings, including written articles, videos, webinars, podcasts, white paper distribution, event sponsorship and more, by reaching out to lisa.guiraud@feedinfo.com

FUFENG US PROJECT HALTED; COMPANY ALSO INVESTIGATING EU PRODUCTION

This quarter, Chinese amino acids producer Fufeng broke ground on a plant in North Dakota which would have been its first production facility in the Americas, but the project was suspended shortly thereafter amid a worsening of the US-China relationship. Fufeng has also been sounding out Bulgarian authorities about potentially building a fermentation facility there.

BASF BUILDING CITRAL CAPACITY IN CHINA

BASF announced that it would be building a new plant for citral production in Zhanjiang, China. Once brought online in 2026, the new plant will boost BASF’s production capacity for citral to 118,000 tonnes/year. Citral is used in the production of vitamins A and E, as well as in other applications.

Paused Vitamin Production Operations Resume

DSM resumed vitamin A production at its site in Sisseln, Switzerland, which had been halted from November through February due to a challenging cost environment. Elsewhere, NHU restarted its vitamin E plant in Weifang, Shandong, in midFebruary; the plant had been shut since 1 January due to the impact of rising COVID-19 infections.

LIFOSA FACES ONGOING OPERATIONAL STRUGGLES, BUT MCP LARGELY UNAFFECTED

Although Lithuanian phosphates producer Lifosa has been forced to pause many of its operations during this quarter as the complexity of sanctions compliance slowed payments to and shipments from suppliers and customers, this was not necessarily an indication that MCP production had shut down. “Feed phosphates are produced on demand, therefore, [production] does not always correspond to the production of other products,” the company told Feedinfo when affirming that MCP production was still taking place during a wider furlough in February.

Increases In Probiotic Production Capacity

Evonik more than doubled its capacity for probiotics production at its facility in León, Spain, where it can now produce the equivalent of 6,000 tonnes of blended final probiotic product per year. ADM, meanwhile, also grew its probiotics production in Spain, opening a new facility which increased its capacity more than five-fold.